| Nov 19 |
GRAIL to Participate in Upcoming Investor Conferences
|
| Nov 18 |
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
|
| Nov 18 |
Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?
|
| Nov 15 |
GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript
|
| Nov 14 |
GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...
|
| Nov 14 |
GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 12 |
GRAIL GAAP EPS of -$3.94, revenue of $28.65M misses by $5.25M
|
| Nov 12 |
GRAIL Reports Third Quarter 2024 Financial Results
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 4 |
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
|
